Enfermedades infecciosas y microbiología clínica
-
Enferm. Infecc. Microbiol. Clin. · Nov 2005
Multicenter Study Comparative Study[Infections caused by Acinetobacter spp. in critically ill ICU patients].
To determine the frequency of infections caused by Acinetobacter spp. in critically ill patients admitted to Spanish intensive care units (ICUs) and to assess the clinical features and outcome. ⋯ Acinetobacter spp. were present in 9.9% of patients with ICU-acquired infection. There were no significant differences in ICU mortality rates between patients with Acinetobacter spp. infection and patients with infections caused by other microorganisms.
-
Enferm. Infecc. Microbiol. Clin. · May 2004
Multicenter Study[Indications for antifungal treatment in intensive care unit patients].
This study investigates the indications for antifungal treatment in patients admitted to intensive care units (ICUs) in Spain and determines the frequency at which each individual drug is prescribed. ⋯ A total of 11.5% of patients included in the study were given one or more treatment courses with antifungal agents. Antifungal treatment was prescribed in proved fungal infections in only 21.1% of cases. Fluconazole was the antifungal agent most frequently used.
-
Enferm. Infecc. Microbiol. Clin. · Feb 2003
Multicenter Study[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Two consensus conferences taking place in the United States and Spain were organized to optimize diagnosis and treatment of Candida spp. infections. Among other results, clinical scenarios in which early prescription of antifungal agents is indicated were identified. ⋯ Adherence to recommendations from the consensus conferences was high among intensive medicine specialists, with no differences according to level of training in infectious diseases.